Creating Drugs
to Watch

We combine extensive data sets and
expertise to identify potential
blockbusters.

Download the report

Drug selection criteria

We draw from expertise from over 160 analysts covering hundreds of diseases, drugs and markets and 11 integrated data sets that span the R&D and commercialization lifecycle.

Download Drugs to Watch 2022

– Please note that Clarivate analysts generated the data shown in the report on December 12, 2021.

Data sources

Since 2013, Clarivate has applied proprietary technologies, tools and techniques trusted by its global life sciences customers to produce the annual Drugs to Watch report.

Resources


Truly differentiate your drug

Access our global intelligence, advanced analytics and global team of experts.

Speak to our team